Please refer to our educational videos for How-To for guidance on subcutaneous injection
On-Label vs Off-Label Use and Regulatory Considerations Because BPC-157 is not approved by the FDA for any indication, any human use is off-label or within research settings
For functional medicine practitioners, biohackers, and researchers, DSIP represents an exciting tool in the expanding toolkit for restoring sleep, rebuilding resilience, and enhancing healthspan
The BPC-157 peptide may work by stimulating growth factors to promote healing, but there is no evidence that it will cause muscle growth to improve body composition
Response monitoring should include subjective symptom tracking, functional assessments, and appropriate objective measures